Dynatrace Sets Fiscal Second-Quarter 2027 Results Announcement
Bitget2026/10/20 12:02- Dynatrace will release fiscal 2027 second-quarter results, covering the period ended Sept. 30, 2026, before U.S. markets open Nov. 3, 2026.
- A conference call and live webcast to discuss results and business outlook will begin at 8 a.m. Eastern Time Nov. 3, 2026.
- An audio replay will remain available until 11:59 p.m. Eastern Time Nov. 17, 2026; an archived webcast will also be available.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
S-Energy Clarifies Solar Contract Value at KRW 11.04 Billion, Reflecting Its Share
Why Snap Needed an Iron Man Star Before Its $2,195 Glasses Go on Sale

Profit surges; amid concerns over U.S. surgical volume, JPMorgan maintains "Overweight" on Intuitive Surgical (ISRG.US) and raises target price to $475
Intuitive Surgical (ISRG.US), the global leader in surgical robots, released its Q3 2026 earnings report on October 20 (U.S. Eastern Time). On the same day, JPMorgan published a research report, maintaining an "Overweight" rating on the stock.
Allergy and autoimmune biotechnology company Lycia Therapeutics (LYCA.US) sets IPO price at $16-18 per share, plans to raise $250 million
Lycia Therapeutics announced the terms of its initial public offering (IPO) on Tuesday.